Psychedelic Spotlight – MINDCURE Targeting Hypoactive Sexual Desire Disorder with MDMA

MINDCURE’s Desire Project explores MDMA’s potential in treating HSDD, a common sexual disorder affecting 9.5 million premenopausal American women. Other market options present side effects such as depression or fatigue. This is the first psychedelic-based research program aimed at HSDD. It attempts to rewire fear-related brain pathways, given that female desire is deeply rooted in the mind.

Access the article here.